Enzyme-linked Immunosorbent Assay Market Size

Enzyme-linked Immunosorbent Assay Market size was over USD 12.64 billion in 2024 and is projected to reach USD 27.63 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of enzyme-linked immunosorbent assay is assessed at USD 13.27 billion.

The growth of this sector can be primarily attributed to the increasing incidence of chronic diseases worldwide. Enzyme-linked immunosorbent assay plays a significant role in detecting, monitoring, and treating these health issues resulting in enhanced patient outcomes.  The cases of chronic diseases globally are expected to grow by 57% by the end of 2025 report as per a report by the World Health Organization This escalating health crisis underscores the critical need for advanced diagnostic tools like ELISA in effectively managing and combating these ailments.

The development of enzyme immunoassays by major industry players contributes to the market's expansion. To identify IgA and IgM antibodies against four SARS-CoV-2 antigens, for example, Bio-Rad introduced the Bio-PlexPro Human IgA and IgM SARS-CoV-2 panels in September 2021. The multiplex immunoassay panels aided in the assessment of therapeutic efficacy by the vaccine developers during the development, clinical, and post-marketing phases.